International Stem Cell Corporation CEO Issues Statement on De-Differentiation Research and Parthenogenesis

OCEANSIDE, Calif.--(BUSINESS WIRE)--Jeff Krstich, Chief Executive Officer of International Stem Cell Corporation (OTCBB:ISCO), today issued a statement on the recent announcement that two groups of scientists have succeeded in turning human skin cells into cells that are very similar, though not identical, to embryonic stem cells.

MORE ON THIS TOPIC